The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

Clinical Significance of Anticholinergic Effects of Imipramine-Like Drugs

Published Online:https://doi.org/10.1176/ajp.125.11.1600

The author compared the antimuscarinic effects on pigeon behavior of amitriptyline, imipramine, and desmethylimipramine (DMI), as well as several other drugs. The results, which did not support the hypothesis that discrete cholinergic mechanisms play an important role in endogenous depression, suggest that DMI may be the antidepressant of choice when the physician wants to minimize atropine-like side effects, while amitriptyline may be chosen when a sedative effect is desired.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.